Skip to content
healthcare.dev
Get a free key

FARXIGA

NDC 70518-4614, DAPAGLIFLOZIN, tablet, film coated, from REMEDYREPACK INC..

Product NDC
70518-4614
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA202293
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4614 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN PROPANEDIOL5 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
70518-4614-07051846140050 POUCH in 1 BOX (70518-4614-0) / 1 TABLET, FILM COATED in 1 POUCH (70518-4614-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ef9e9c8c-5460-4193-952a-0c249dd071bd

Use it

Look up 70518-4614 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4614 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-4614. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.